|
Volumn 17, Issue 1, 2004, Pages 43-57
|
The Year's New Drugs
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABARELIX;
ACETYLSALICYLIC ACID;
ADALIMUMAB;
ALEFACEPT;
ALPHA 1 ANTITRYPSIN;
AMPRENAVIR PHOSPHATE;
ANALGESIC AGENT;
ANTINEOPLASTIC AGENT;
ANTIPARKINSON AGENT;
APREPITANT;
ATAZANAVIR;
ATOMOXETINE;
AZELNIDIPINE;
BORTEZOMIB;
CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA;
CETUXIMAB;
CISPLATIN;
CORTICOSTEROID;
CYCLOOXYGENASE 2 INHIBITOR;
CYCLOSPORIN A;
DAPTOMYCIN;
DROSPIRENONE PLUS ESTRADIOL;
DUTASTERIDE;
EFALIZUMAB;
EMTRICITABINE;
ENFUVIRTIDE;
EPINASTINE;
EPLERENONE;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
EVEROLIMUS;
FLUOXETINE PLUS OLANZAPINE;
FOSFLUCONAZOLE;
GATIFLOXACIN;
HUMAN GROWTH HORMONE;
IBANDRONIC ACID;
ILOPROST;
INFLIXIMAB;
INFLUENZA VACCINE;
LARONIDASE;
LITHIUM;
LUMIRACOXIB;
MIGLUSTAT;
MONTELUKAST;
MOXIFLOXACIN;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NEUROLEPTIC AGENT;
NEW DRUG;
OLMESARTAN;
OMALIZUMAB;
OXYBUTYNIN;
PALONOSETRON;
PEGVISOMANT;
PITAVASTATIN;
PRAVASTATIN;
PRAVIGARD;
QUETIAPINE;
RC 529;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
RISPERIDONE;
ROSUVASTATIN;
RUPATADINE;
SILDENAFIL;
TADALAFIL;
TESTOSTERONE;
TESTOSTERONE UNDECANOATE;
TOSITUMOMAB I 131;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALPROIC ACID;
VARDENAFIL;
ATTENTION DEFICIT DISORDER;
CARDIOTOXICITY;
CLINICAL TRIAL;
DIAGNOSTIC TEST;
DRUG DEPENDENCE;
DRUG RESEARCH;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
HYPERTENSION;
MARKETING;
MENTAL DISEASE;
NAUSEA;
OSTEOARTHRITIS;
PRACTICE GUIDELINE;
REVIEW;
UNITED STATES;
VOMITING;
PHARMACEUTICAL PREPARATIONS;
|
EID: 1842424440
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (19)
|
References (0)
|